Skip to content

The effect of probiotics on depressive symptoms in depressed patients

The effect of probiotics on depressive symptoms in depressed patients - The effect of probiotics on depressive symptoms in depressed patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032825
Enrollment
20
Registered
2018-06-01
Start date
2018-05-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Intake probiotics for 3 months. (L. casei YIT 9029)

Sponsors

National Center of Neurology and Psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Depressed patient (HAM-D score more than 11 point). (2)Subjects showing a sufficient understanding of the clinical trial procedure and agreeing to participate in the study by written informed consent at his own will. (3)For Japanese who aged 20 or over and under 65 years old when acquiring (4)Right-handed person

Exclusion criteria

Exclusion criteria: (1)Subjects who have a history of cardiovascular disease, liver disease, kidney disease, digestive tract disease and diabetes. (2)Subjects suspected to suffer from alcohol dependence and / or drug dependence. (3)Subjects who have a specific configuration that occur allergy and / or hypersensitivity against test drinks. (4)Marked suicidal ideation as indexed by three points or more on the "suicide" item of HAM-D. (5)Subjects who have edema in the brain. (6)Subjects who are diagnosed as a complication of dementia or intellectual disability. (7)Subjects who are lactating and/or pregnant. (8)Subjects who have a contraindication to MRI, such as claustrophobia, tattoo, implanted electrical device (e.g. cardiac pacemaker). (9)Those who have suffered serious head trauma or a central nervous system disease. (10)Subjects who are judged as unfit for the subject by the principal investigator

Design outcomes

Primary

MeasureTime frame
1. Hamilton Depression Rating Scale(HAM-D) 2. Mini-International Neuropsychiatric Interview 3. ROME-III/ IV 4.Distribution of bacterial in feces

Secondary

MeasureTime frame
1. Psychometric tests 2. Plasma/Serum hormones 3. Magnetic resonance imaging

Countries

Japan

Contacts

Public ContactHiroshi Kunugi

National Center of Neurology and Psychiatry Department of Mental Disorder Research

hkunugi@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026